Glycosphingolipids as receptors for non-enveloped viruses

Viruses

Volumn 2, Issue 4, 2010, Pages 1011-1049

  Taube, Stefan ^a   Jiang, Mengxi ^a   Wobus, Christiane E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Calicivirus; Glycosphingolipid; Non enveloped virus; Parvovirus; Polyomavirus; Receptor; Rotavirus

Indexed keywords

FUCOSYLTRANSFERASE; GLOBOSIDE; GLYCOSPHINGOLIPID; SIALIDASE; VIRUS RECEPTOR;

ADENO ASSOCIATED VIRUS; BINDING AFFINITY; BK VIRUS; CALICIVIRUS; CARBOHYDRATE ANALYSIS; GENOME ANALYSIS; HUMAN; HUMAN PARVOVIRUS B19; HUMAN ROTAVIRUS; JC VIRUS; LAGOVIRUS; LIPOGENESIS; NONHUMAN; NOROVIRUS; PARVOVIRUS; POLYOMA VIRUS; REVIEW; ROTAVIRUS; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; STRUCTURE ANALYSIS; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS STRAIN;

CALICIVIRIDAE; PARVOVIRUS; POLYOMAVIRUS; ROTAVIRUS;

EID: 78049507903     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v2041011     Document Type: Review

References (215)

1. Helenius, A. Virus entry and uncoating. In Fields Virology; 5 ed.; Knipe, D. M., Howley, P. M., Ed. Wolters Kluwer: Philadelphia, 2007; Vol. 1, pp. 99-118.
2. Olofsson, S.; Bergstrom, T. Glycoconjugate glycans as viral receptors. Ann. Med. 2005, 37, 154-172.
3. Iwamori, M. A new turning point in glycosphingolipid research. Hum. Cell 2005, 18, 117-133.
4. Prinetti, A.; Loberto, N.; Chigorno, V.; Sonnino, S. Glycosphingolipid behaviour in complex membranes. Biochim. Biophys. Acta 2009, 1788, 184-193.
5. Hakomori, S. Structure, organization, and function of glycosphingolipids in membrane. Curr. Opin. Hematol. 2003, 10, 16-24.
6. Chester, M.A. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids--recommendations 1997. Eur. J. Biochem. 1998, 257, 293-298.
7. Spitalnik, P.F.; Spitalnik, S.L. The P blood group system: biochemical, serological, and clinical aspects. Transfus. Med. Rev. 1995, 9, 110-122.
8. Hakomori, S. Traveling for the glycosphingolipid path. Glycoconj. J. 2000, 17, 627-647.
9. Karlsson, K.A. Animal glycosphingolipids as membrane attachment sites for bacteria. Annu. Rev. Biochem. 1989, 58, 309-350.
10. Green, K.Y. Caliciviridae. In Fields Virology; 5 ed.; D. M. Knipe, P. M. H., Ed. Lippincott Williams & Wilkins: Philadelphia, 2007; Vol. 1, pp. 949-980.
11. Farkas, T.; Sestak, K.; Wei, C.; Jiang, X. Characterization of a rhesus monkey calicivirus representing a new genus of Caliciviridae. J. Virol. 2008, 82, 5408-5416.
12. Oliver, S.L.; Asobayire, E.; Dastjerdi, A.M.; Bridger, J.C. Genomic characterization of the unclassified bovine enteric virus Newbury agent-1 (Newbury1) endorses a new genus in the family Caliciviridae. Virology 2006, 350, 240-250.
13. Sosnovtsev, S.V.; Green, K.Y. Identification and genomic mapping of the ORF3 and VPg proteins in feline calicivirus virions. Virology 2000, 277, 193-203.
14. Thackray, L.B.; Wobus, C.E.; Chachu, K.A.; Liu, B.; Alegre, E.R.; Henderson, K.S.; Kelley, S.T.; Virgin, H.W. Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence. J. Virol. 2007, 81, 10460-10473.
15. Prasad, B.V.; Hardy, M.E.; Dokland, T.; Bella, J.; Rossmann, M.G.; Estes, M.K. X-ray crystallographic structure of the Norwalk virus capsid. Science 1999, 286, 287-290.
16. Prasad, B.V.; Hardy, M.E.; Jiang, X.; Estes, M.K. Structure of Norwalk virus. Arch. Virol. Suppl. 1996, 12, 237-242.
17. Prasad, B.V.; Rothnagel, R.; Jiang, X.; Estes, M.K. Three-dimensional structure of baculovirus-expressed Norwalk virus capsids. J. Virol. 1994, 68, 5117-5125.
18. Katpally, U.; Wobus, C.E.; Dryden, K.; Virgin, H.W.; Smith, T.J. Structure of antibody-neutralized murine norovirus and unexpected differences from viruslike particles. J. Virol. 2008, 82, 2079-2088.
19. Chen, R.; Neill, J.D.; Noel, J.S.; Hutson, A.M.; Glass, R.I.; Estes, M.K.; Prasad, B.V. Inter- and intragenus structural variations in caliciviruses and their functional implications. J. Virol. 2004, 78, 6469-6479.
20. Chen, R.; Neill, J.D.; Estes, M.K.; Prasad, B.V. X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 8048-8053.
21. Tan, M.; Hegde, R.S.; Jiang, X. The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J. Virol. 2004, 78, 6233-6242.
22. Bertolotti-Ciarlet, A.; White, L.J.; Chen, R.; Prasad, B.V.; Estes, M.K. Structural requirements for the assembly of Norwalk virus-like particles. J. Virol. 2002, 76, 4044-4055.
23. Katpally, U.; Voss, N.R.; Cavazza, T.; Taube, S.; Rubin, J.R.; Young, V.L.; Stuckey, J.; Ward, V.K.; Virgin, H.W.t.; Wobus, C.E.; Smith, T.J. High-resolution cryo-electron microscopy structures of MNV-1 and RHDV reveals marked flexibility in the receptor binding domains. J. Virol. 2010, [Epub ahead of print].
24. Taube, S.; Rubin, J.R.; Katpally, U.; Smith, T.J.; Kendall, A.; Stuckey, J.A.; Wobus, C.E. High Resolution X-Ray Structure and Functional Analysis of the Murine Norovirus (MNV)-1 Capsid Protein Protruding (P) Domain. J. Virol. 2010, [Epub ahead of print].
25. Bu, W.; Mamedova, A.; Tan, M.; Xia, M.; Jiang, X.; Hegde, R.S. Structural basis for the receptor binding specificity of Norwalk virus. J. Virol. 2008, 82, 5340-5347.
26. Choi, J.M.; Hutson, A.M.; Estes, M.K.; Prasad, B.V. Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 9175-9180.
27. Cao, S.; Lou, Z.; Tan, M.; Chen, Y.; Liu, Y.; Zhang, Z.; Zhang, X.C.; Jiang, X.; Li, X.; Rao, Z. Structural basis for the recognition of blood group trisaccharides by norovirus. J. Virol. 2007, 81, 5949-5957.
28. Santi, L.; Batchelor, L.; Huang, Z.; Hjelm, B.; Kilbourne, J.; Arntzen, C.J.; Chen, Q.; Mason, H.S. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 2008, 26, 1846-1854.
29. Green, K.Y.; Lew, J.F.; Jiang, X.; Kapikian, A.Z.; Estes, M.K. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J. Clin. Microbiol. 1993, 31, 2185-2191.
30. Taube, S.; Kurth, A.; Schreier, E. Generation of recombinant norovirus-like particles (VLP) in the human endothelial kidney cell line 293T. Arch. Virol. 2005, 150, 1425-1431.
31. Jiang, X.; Wang, M.; Graham, D.Y.; Estes, M.K. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 1992, 66, 6527-6532.
32. Harrington, P.R.; Yount, B.; Johnston, R.E.; Davis, N.; Moe, C.; Baric, R.S. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles. J. Virol. 2002, 76, 730-742.
33. Zhang, X.; Buehner, N.A.; Hutson, A.M.; Estes, M.K.; Mason, H.S. Tomato is a highly effective vehicle for expression and oral immunization with Norwalk virus capsid protein. Plant Biotechnol. J. 2006, 4, 419-432.
34. Wobus, C.E.; Karst, S.M.; Thackray, L.B.; Chang, K.O.; Sosnovtsev, S.V.; Belliot, G.; Krug, A.; Mackenzie, J.M.; Green, K.Y.; Virgin, H.W. Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol. 2004, 2, e432.
35. Parwani, A.V.; Flynn, W.T.; Gadfield, K.L.; Saif, L.J. Serial propagation of porcine enteric calicivirus in a continuous cell line. Effect of medium supplementation with intestinal contents or enzymes. Arch. Virol. 1991, 120, 115-122.
36. Bidawid, S.; Malik, N.; Adegbunrin, O.; Sattar, S.A.; Farber, J.M. A feline kidney cell line-based plaque assay for feline calicivirus, a surrogate for Norwalk virus. J. Virol. Methods 2003, 107, 163-167.
37. Stuart, A.D.; Brown, T.D. Alpha2,6-linked sialic acid acts as a receptor for Feline calicivirus. J. Gen. Virol. 2007, 88, 177-186.
38. Ossiboff, R.J.; Parker, J.S. Identification of regions and residues in feline junctional adhesion molecule required for feline calicivirus binding and infection. J. Virol. 2007, 81, 13608-13621.
39. Makino, A.; Shimojima, M.; Miyazawa, T.; Kato, K.; Tohya, Y.; Akashi, H. Junctional adhesion molecule 1 is a functional receptor for feline calicivirus. J. Virol. 2006, 80, 4482-4490.
40. Stuart, A.D.; Brown, T.D. Entry of feline calicivirus is dependent on clathrin-mediated endocytosis and acidification in endosomes. J. Virol. 2006, 80, 7500-7509.
41. Gerondopoulos, A.; Jackson, T.; Monaghan, P.; Doyle, N.; Roberts, L.O. Murine norovirus-1 cell entry is mediated through a non-clathrin, non-caveolae, dynamin and cholesterol dependent pathway. J. Gen. Virol. 2010, [Epub ahead of print].
42. Perry, J.W.; Taube, S.; Wobus, C.E. Murine norovirus-1 entry into permissive macrophages and dendritic cells is pH-independent. Virus Res. 2009, 143, 125-129.
43. Perry, J.; Wobus, C.E. Endocytosis of Murine Norovirus 1 into Murine Macrophages is dependent on dynamin II and cholesterol. J. Virol. 2010, 84, in press.
44. Estes, M.K.; Prasad, B.V.; Atmar, R.L. Noroviruses everywhere: has something changed? Curr. Opin. Infect. Dis. 2006, 19, 467-474.
45. Widdowson, M.A.; Monroe, S.S.; Glass, R.I. Are noroviruses emerging? Emerg. Infect. Dis. 2005, 11, 735-737.
46. Koopmans, M.; Duizer, E. Foodborne viruses: an emerging problem. Int. J. Food Microbiol. 2004, 90, 23-41.
47. Skovgaard, N. New trends in emerging pathogens. Int. J. Food Microbiol. 2007, 120, 217-224.
48. Karst, S.M.; Wobus, C.E.; Lay, M.; Davidson, J.; Virgin IV, H.W. STAT1-dependent innate immunity to a Norwalk-like virus. Science 2003, 299, 1575-1578.
49. Martella, V.; Lorusso, E.; Decaro, N.; Elia, G.; Radogna, A.; D'Abramo, M.; Desario, C.; Cavalli, A.; Corrente, M.; Camero, M.; Germinario, C.A.; Banyai, K.; Di Martino, B.; Marsilio, F.; Carmichael, L.E.; Buonavoglia, C. Detection and molecular characterization of a canine norovirus. Emerg. Infect. Dis. 2008, 14, 1306-1308.
50. van Der Poel, W.H.; Vinje, J.; van Der Heide, R.; Herrera, M.I.; Vivo, A.; Koopmans, M.P. Norwalk-like calicivirus genes in farm animals. Emerg. Infect. Dis. 2000, 6, 36-41.
51. Wise, A.G.; Monroe, S.S.; Hanson, L.E.; Grooms, D.L.; Sockett, D.; Maes, R.K. Molecular characterization of noroviruses detected in diarrheic stools of Michigan and Wisconsin dairy calves: circulation of two distinct subgroups. Virus Res. 2004, 100, 165-177.
52. Wolf, S.; Williamson, W.; Hewitt, J.; Lin, S.; Rivera-Aban, M.; Ball, A.; Scholes, P.; Savill, M.; Greening, G.E. Molecular detection of norovirus in sheep and pigs in New Zealand farms. Vet. Microbiol. 2008.
53. Zheng, D.P.; Ando, T.; Fankhauser, R.L.; Beard, R.S.; Glass, R.I.; Monroe, S.S. Norovirus classification and proposed strain nomenclature. Virology 2006, 346, 312-323.
54. Donaldson, E.F.; Lindesmith, L.C.; Lobue, A.D.; Baric, R.S. Viral shape-shifting: norovirus evasion of the human immune system. Nat. Rev. Microbiol. 2010, 8, 231-241.
55. Lopman, B.; Vennema, H.; Kohli, E.; Pothier, P.; Sanchez, A.; Negredo, A.; Buesa, J.; Schreier, E.; Reacher, M.; Brown, D.; Gray, J.; Iturriza, M.; Gallimore, C.; Bottiger, B.; Hedlund, K.O.; Torven, M.; von Bonsdorff, C.H.; Maunula, L.; Poljsak-Prijatelj, M.; Zimsek, J.; Reuter, G.; Szucs, G.; Melegh, B.; Svennson, L.; van Duijnhoven, Y.; Koopmans, M. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. Lancet 2004, 363, 682-688.
56. Widdowson, M.A.; Cramer, E.H.; Hadley, L.; Bresee, J.S.; Beard, R.S.; Bulens, S.N.; Charles, M.; Chege, W.; Isakbaeva, E.; Wright, J.G.; Mintz, E.; Forney, D.; Massey, J.; Glass, R.I.; Monroe, S.S. Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus--United States, 2002. J. Infect. Dis. 2004, 190, 27-36.
57. White, P.A.; Hansman, G.S.; Li, A.; Dable, J.; Isaacs, M.; Ferson, M.; McIver, C.J.; Rawlinson, W.D. Norwalk-like virus 95/96-US strain is a major cause of gastroenteritis outbreaks in Australia. J. Med. Virol. 2002, 68, 113-118.
58. Guix, S.; Asanaka, M.; Katayama, K.; Crawford, S.E.; Neill, F.H.; Atmar, R.L.; Estes, M.K. Norwalk virus RNA is infectious in mammalian cells. J. Virol. 2007, 81, 12238-12248.
59. Mead, P.S.; Slutsker, L.; Dietz, V.; McCaig, L.F.; Bresee, J.S.; Shapiro, C.; Griffin, P.M.; Tauxe, R.V. Food-related illness and death in the United States. Emerg. Infect. Dis. 1999, 5, 607-625.
60. Duizer, E.; Schwab, K.J.; Neill, F.H.; Atmar, R.L.; Koopmans, M.P.; Estes, M.K. Laboratory efforts to cultivate noroviruses. J. Gen. Virol. 2004, 85, 79-87.
61. Le Pendu, J.; Ruvoen-Clouet, N.; Kindberg, E.; Svensson, L. Mendelian resistance to human norovirus infections. Semin. Immunol. 2006, 18, 375-386.
62. Tan, M.; Jiang, X. Norovirus-host interaction: implications for disease control and prevention. Exp. Rev. Mol. Med. 2007, 9, 1-22.
63. Tamura, M.; Natori, K.; Kobayashi, M.; Miyamura, T.; Takeda, N. Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane. J. Virol. 2004, 78, 3817-3826.
64. Rydell, G.E.; Nilsson, J.; Rodriguez-Diaz, J.; Ruvoen-Clouet, N.; Svensson, L.; Le Pendu, J.; Larson, G. Human noroviruses recognize sialyl Lewis x neoglycoprotein. Glycobiology 2009, 19, 309-320.
65. Clausen, H.; Hakomori, S. ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang. 1989, 56, 1-20.
66. Henry, S.M.; Samuelsson, B.E.; Oriol, R. Immunochemical and immunohistological expression of Lewis histo-blood group antigens in small intestine including individuals of the Le(a+b+) and Le(a-b-) nonsecretor phenotypes. Glycoconj. J. 1994, 11, 600-607.
67. Marionneau, S.; Cailleau-Thomas, A.; Rocher, J.; Le Moullac-Vaidye, B.; Ruvoen, N.; Clement, M.; Le Pendu, J. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 2001, 83, 565-573.
68. Le Pendu, J. Histo-blood group antigen and human milk oligosaccharides: genetic polymorphism and risk of infectious diseases. Adv. Exp. Med. Biol. 2004, 554, 135-143.
69. Hakomori, S. Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim. Biophys. Acta 1999, 1473, 247-266.
70. Taube, S.; Perry, J.W.; Yetming, K.; Patel, S.P.; Auble, H.; Shu, L.; Nawar, H.F.; Lee, C.H.; Connell, T.D.; Shayman, J.A.; Wobus, C.E. Ganglioside-linked terminal sialic acid moieties on murine macrophages function as attachment receptors for murine noroviruses. J. Virol. 2009, 83, 4092-4101.
71. Zakhour, M.; Ruvoen-Clouet, N.; Charpilienne, A.; Langpap, B.; Poncet, D.; Peters, T.; Bovin, N.; Le Pendu, J. The alphaGal epitope of the histo-blood group antigen family is a ligand for bovine norovirus Newbury2 expected to prevent cross-species transmission. PLoS Path. 2009, 5, e1000504.
72. Ruvoen-Clouet, N.; Ganiere, J.P.; Andre-Fontaine, G.; Blanchard, D.; Le Pendu, J. Binding of rabbit hemorrhagic disease virus to antigens of the ABH histo-blood group family. J. Virol. 2000, 74, 11950-11954.
73. Isa, P.; Gutierrez, M.; Arias, C.F.; Lopez, S. Rotavirus cell entry. Future Medicine 2008, 3, 135-146.
74. Rolsma, M.D.; Gelberg, H.B.; Kuhlenschmidt, M.S. Assay for evaluation of rotavirus-cell interactions: identification of an enterocyte ganglioside fraction that mediates group A porcine rotavirus recognition. J. Virol. 1994, 68, 258-268.
75. Rolsma, M.D.; Kuhlenschmidt, T.B.; Gelberg, H.B.; Kuhlenschmidt, M.S. Structure and function of a ganglioside receptor for porcine rotavirus. J. Virol. 1998, 72, 9079-9091.
76. Haselhorst, T.; Fleming, F.E.; Dyason, J.C.; Hartnell, R.D.; Yu, X.; Holloway, G.; Santegoets, K.; Kiefel, M.J.; Blanchard, H.; Coulson, B.S.; von Itzstein, M. Sialic acid dependence in rotavirus host cell invasion. Nat. Chem. Biol. 2009, 5, 91-93.
77. Delorme, C.; Brussow, H.; Sidoti, J.; Roche, N.; Karlsson, K.A.; Neeser, J.R.; Teneberg, S. Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J. Virol. 2001, 75, 2276-2287.
78. Dormitzer, P.R.; Sun, Z.Y.; Blixt, O.; Paulson, J.C.; Wagner, G.; Harrison, S.C. Specificity and affinity of sialic acid binding by the rhesus rotavirus VP8* core. J. Virol. 2002, 76, 10512-10517.
79. Guo, C.T.; Nakagomi, O.; Mochizuki, M.; Ishida, H.; Kiso, M.; Ohta, Y.; Suzuki, T.; Miyamoto, D.; Hidari, K.I.; Suzuki, Y. Ganglioside GM(1a) on the cell surface is involved in the infection by human rotavirus KUN and MO strains. J. Biochem. (Tokyo). 1999, 126, 683-688.
80. Tsai, B.; Gilbert, J.M.; Stehle, T.; Lencer, W.; Benjamin, T.L.; Rapoport, T.A. Gangliosides are receptors for murine polyoma virus and SV40. EMBO J. 2003, 22, 4346-4355.
81. Stehle, T.; Harrison, S.C. Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. Structure 1996, 4, 183-194.
82. Caruso, M.; Belloni, L.; Sthandier, O.; Amati, P.; Garcia, M.I. Alpha4beta1 integrin acts as a cell receptor for murine polyomavirus at the postattachment level. J. Virol. 2003, 77, 3913-3921.
83. Caruso, M.; Busanello, A.; Sthandier, O.; Cavaldesi, M.; Gentile, M.; Garcia, M.I.; Amati, P. Mutation in the VP1-LDV motif of the murine polyomavirus affects viral infectivity and conditions virus tissue tropism in vivo. J. Mol. Biol. 2007, 367, 54-64.
84. Breau, W.C.; Atwood, W.J.; Norkin, L.C. Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor. J. Virol. 1992, 66, 2037-2045.
85. Atwood, W.J.; Norkin, L.C. Class I major histocompatibility proteins as cell surface receptors for simian virus 40. J. Virol. 1989, 63, 4474-4477.
86. Low, J.A.; Magnuson, B.; Tsai, B.; Imperiale, M.J. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J. Virol. 2006, 80, 1361-1366.
87. Dugan, A.S.; Eash, S.; Atwood, W.J. An N-linked glycoprotein with alpha(2,3)-linked sialic acid is a receptor for BK virus. J. Virol. 2005, 79, 14442-14445.
88. Komagome, R.; Sawa, H.; Suzuki, T.; Suzuki, Y.; Tanaka, S.; Atwood, W.J.; Nagashima, K. Oligosaccharides as receptors for JC virus. J. Virol. 2002, 76, 12992-13000.
89. Elphick, G.F.; Querbes, W.; Jordan, J.A.; Gee, G.V.; Eash, S.; Manley, K.; Dugan, A.; Stanifer, M.; Bhatnagar, A.; Kroeze, W.K.; Roth, B.L.; Atwood, W.J. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004, 306, 1380-1383.
90. Dugan, A.S.; Gasparovic, M.L.; Atwood, W.J. Direct correlation between sialic acid binding and infection of cells by two human polyomaviruses (JC virus and BK virus). J. Virol. 2008, 82, 2560-2564.
91. Liu, C.K.; Wei, G.; Atwood, W.J. Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids. J. Virol. 1998, 72, 4643-4649.
92. Erickson, K.D.; Garcea, R.L.; Tsai, B. Ganglioside GT1b is a putative host cell receptor for the Merkel cell polyomavirus. J. Virol. 2009, 83, 10275-10279.
93. Brown, K.E.; Anderson, S.M.; Young, N.S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993, 262, 114-117.
94. Cooling, L.L.; Koerner, T.A.; Naides, S.J. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J. Infect. Dis. 1995, 172, 1198-1205.
95. Weigel-Kelley, K.A.; Yoder, M.C.; Srivastava, A. Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 2003, 102, 3927-3933.
96. Munakata, Y.; Saito-Ito, T.; Kumura-Ishii, K.; Huang, J.; Kodera, T.; Ishii, T.; Hirabayashi, Y.; Koyanagi, Y.; Sasaki, T. Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 2005, 106, 3449-3456.
97. Brown, K.E.; Liu, Z.; Gallinella, G.; Wong, S.; Mills, I.P.; O'Sullivan, M.G. Simian parvovirus infection: a potential zoonosis. J. Infect. Dis. 2004, 190, 1900-1907.
98. Schmidt, M.; Chiorini, J.A. Gangliosides are essential for bovine adeno-associated virus entry. J. Virol. 2006, 80, 5516-5522.
99. Hakomori, S.I. Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. Biochim. Biophys. Acta 2008, 1780, 325-346.
100. Ravn, V.; Dabelsteen, E. Tissue distribution of histo-blood group antigens. APMIS 2000, 108, 1-28.
101. Kelly, R.J.; Ernst, L.K.; Larsen, R.D.; Bryant, J.G.; Robinson, J.S.; Lowe, J.B. Molecular basis for H blood group deficiency in Bombay (Oh) and para-Bombay individuals. Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 5843-5847.
102. Harrington, P.R.; Lindesmith, L.; Yount, B.; Moe, C.L.; Baric, R.S. Binding of Norwalk viruslike particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J. Virol. 2002, 76, 12335-12343.
103. Harrington, P.R.; Vinje, J.; Moe, C.L.; Baric, R.S. Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions. J. Virol. 2004, 78, 3035-3045.
104. Hutson, A.M.; Atmar, R.L.; Marcus, D.M.; Estes, M.K. Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J. Virol. 2003, 77, 405-415.
105. Lindesmith, L.; Moe, C.; Marionneau, S.; Ruvoen, N.; Jiang, X.; Lindblad, L.; Stewart, P.; LePendu, J.; Baric, R. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 2003, 9, 548-553.
106. Marionneau, S.; Ruvoen, N.; Le Moullac-Vaidye, B.; Clement, M.; Cailleau-Thomas, A.; Ruiz-Palacois, G.; Huang, P.; Jiang, X.; Le Pendu, J. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology 2002, 122, 1967-1977.
107. Huang, P.; Farkas, T.; Marionneau, S.; Zhong, W.; Ruvoen-Clouet, N.; Morrow, A.L.; Altaye, M.; Pickering, L.K.; Newburg, D.S.; LePendu, J.; Jiang, X. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J. Infect. Dis. 2003, 188, 19-31.
108. Hutson, A.M.; Atmar, R.L.; Graham, D.Y.; Estes, M.K. Norwalk virus infection and disease is associated with ABO histo-blood group type. J. Infect. Dis. 2002, 185, 1335-1337.
109. Nilsson, J.; Rydell, G.E.; Le Pendu, J.; Larson, G. Norwalk virus-like particles bind specifically to A, H and difucosylated Lewis but not to B histo-blood group active glycosphingolipids. Glycoconj. J. 2009.
110. Rydell, G.E.; Dahlin, A.B.; Hook, F.; Larson, G. QCM-D studies of human norovirus VLPs binding to glycosphingolipids in supported lipid bilayers reveal strain-specific characteristics. Glycobiology 2009, 19, 1176-1184.
111. Shirato, H.; Ogawa, S.; Ito, H.; Sato, T.; Kameyama, A.; Narimatsu, H.; Xiaofan, Z.; Miyamura, T.; Wakita, T.; Ishii, K.; Takeda, N. Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding. J. Virol. 2008.
112. Rockx, B.H.; Vennema, H.; Hoebe, C.J.; Duizer, E.; Koopmans, M.P. Association of histo-blood group antigens and susceptibility to norovirus infections. J. Infect. Dis. 2005, 191, 749-754.
113. Hennessy, E.P.; Green, A.D.; Connor, M.P.; Darby, R.; MacDonald, P. Norwalk virus infection and disease is associated with ABO histo-blood group type. J. Infect. Dis. 2003, 188, 176-177.
114. Marionneau, S.; Airaud, F.; Bovin, N.V.; Le Pendu, J.; Ruvoen-Clouet, N. Influence of the combined ABO, FUT2, and FUT3 polymorphism on susceptibility to Norwalk virus attachment. J. Infect. Dis. 2005, 192, 1071-1077.
115. Larsson, M.M.; Rydell, G.E.; Grahn, A.; Rodriguez-Diaz, J.; Akerlind, B.; Hutson, A.M.; Estes, M.K.; Larson, G.; Svensson, L. Antibody prevalence and titer to norovirus (genogroup II) correlate with secretor (FUT2) but not with ABO phenotype or Lewis (FUT3) genotype. J. Infect. Dis. 2006, 194, 1422-1427.
116. Lindesmith, L.; Moe, C.; Lependu, J.; Frelinger, J.A.; Treanor, J.; Baric, R.S. Cellular and humoral immunity following Snow Mountain virus challenge. J. Virol. 2005, 79, 2900-2909.
117. Lindesmith, L.C.; Donaldson, E.F.; Lobue, A.D.; Cannon, J.L.; Zheng, D.P.; Vinje, J.; Baric, R.S. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med. 2008, 5, e31.
118. Donaldson, E.F.; Lindesmith, L.C.; Lobue, A.D.; Baric, R.S. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Immunol. Rev. 2008, 225, 190-211.
119. Hsu, C.C.; Wobus, C.E.; Steffen, E.K.; Riley, L.K.; Livingston, R.S. Development of a microsphere-based serologic multiplexed fluorescent immunoassay and a reverse transcriptase PCR assay to detect murine norovirus 1 infection in mice. Clin. Diagn. Lab. Immunol. 2005, 12, 1145-1151.
120. Muller, B.; Klemm, U.; Mas Marques, A.; Schreier, E. Genetic diversity and recombination of murine noroviruses in immunocompromised mice. Arch. Virol. 2007, 152, 1709-1719.
121. Henderson, K.S. Murine norovirus, a recently discovered and highly prevalent viral agent of mice. Lab Anim (NY) 2008, 37, 314-320.
122. Mahler, M.; Kohl, W. A serological survey to evaluate contemporary prevalence of viral agents and Mycoplasma pulmonis in laboratory mice and rats in western Europe. Lab Anim (NY) 2009, 38, 161-165.
123. Kitajima, M.; Oka, T.; Tohya, Y.; Katayama, H.; Takeda, N.; Katayama, K. Development of a broadly reactive nested reverse transcription-PCR assay to detect murine noroviruses, and investigation of the prevalence of murine noroviruses in laboratory mice in Japan. Microbiol. Immunol. 2009, 53, 531-534.
124. Kim, M.; Lee, H.; Chang, K.O.; Ko, G. Molecular characterization of murine norovirus isolates from South Korea. Virus Res. 2010, 147, 1-6.
125. Wobus, C.E.; Thackray, L.B.; Virgin, H.W. Murine norovirus: a model system to study norovirus biology and pathogenesis. J. Virol. 2006, 80, 5104-5112.
126. Woode, G.N.; Bridger, J.C. Isolation of small viruses resembling astroviruses and caliciviruses from acute enteritis of calves. J. Med. Microbiol. 1978, 11, 441-452.
127. Guillon, P.; Ruvoen-Clouet, N.; Le Moullac-Vaidye, B.; Marchandeau, S.; Le Pendu, J. Association between expression of the H histo-blood group antigen, alpha1,2fucosyltransferases polymorphism of wild rabbits, and sensitivity to rabbit hemorrhagic disease virus. Glycobiology 2009, 19, 21-28.
128. Guittre, C.; Ruvoen-Clouet, N.; Barraud, L.; Cherel, Y.; Baginski, I.; Prave, M.; Ganiere, J.P.; Trepo, C.; Cova, L. Early stages of rabbit haemorrhagic disease virus infection monitored by polymerase chain reaction. Zentralbl. Veterinarmed. [B]. 1996, 43, 109-118.
129. Park, J.H.; Ochiai, K.; Itakura, C. Detection of rabbit haemorrhagic disease virus particles in the rabbit liver tissues. J. Comp. Pathol. 1992, 107, 329-340.
130. Laurent, S.; Vautherot, J.F.; Madelaine, M.F.; Le Gall, G.; Rasschaert, D. Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection. J. Virol. 1994, 68, 6794-6798.
131. Rademacher, C.; Krishna, N.R.; Palcic, M.; Parra, F.; Peters, T. NMR experiments reveal the molecular basis of receptor recognition by a calicivirus. J. Am. Chem. Soc. 2008, 130, 3669-3675.
132. Morisse, J.P.; Le Gall, G.; Boilletot, E. Hepatitis of viral origin in Leporidae: introduction and aetiological hypotheses. Rev. Sci. Tech. 1991, 10, 269-310.
133. Rodak, L.; Smid, B.; Valicek, L. Application of control measures against viral haemorrhagic disease of rabbits in the Czech and Slovak Federal Republic. Rev. Sci. Tech. 1991, 10, 513-524.
134. Lopez, S.; Arias, C.F. Early steps in rotavirus cell entry. Curr. Top. Microbiol. Immunol. 2006, 309, 39-66.
135. Lorrot, M.; Vasseur, M. How do the rotavirus NSP4 and bacterial enterotoxins lead differently to diarrhea? Virol. J. 2007, 4, 31.
136. Isa, P.; Arias, C.F.; Lopez, S. Role of sialic acids in rotavirus infection. Glycoconj. J. 2006, 23, 27-37.
137. Ciarlet, M.; Crawford, S.E.; Cheng, E.; Blutt, S.E.; Rice, D.A.; Bergelson, J.M.; Estes, M.K. VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment. J. Virol. 2002, 76, 1109-1123.
138. Trask, S.D.; Kim, I.S.; Harrison, S.C.; Dormitzer, P.R. A rotavirus spike protein conformational intermediate binds lipid bilayers. J. Virol. 2010, 84, 1764-1770.
139. Dowling, W.; Denisova, E.; LaMonica, R.; Mackow, E.R. Selective membrane permeabilization by the rotavirus VP5* protein is abrogated by mutations in an internal hydrophobic domain. J. Virol. 2000, 74, 6368-6376.
140. Keljo, D.J.; Smith, A.K. Characterization of binding of simian rotavirus SA-11 to cultured epithelial cells. J. Pediatr. Gastroenterol. Nutr. 1988, 7, 249-256.
141. Bastardo, J.W.; Holmes, I.H. Attachment of SA-11 rotavirus to erythrocyte receptors. Infect. Immun. 1980, 29, 1134-1140.
142. Fauvel, M.; Spence, L.; Babiuk, L.A.; Petro, R.; Bloch, S. Hemagglutination and hemagglutination-inhibition studies with a strain of Nebraska calf diarrhea virus (bovine rotavirus). Intervirology 1978, 9, 95-105.
143. Spence, L.; Fauvel, M.; Petro, R.; Babiuk, L.A. Comparison of rotavirus strains by hemagglutination inhibition. Can. J. Microbiol. 1978, 24, 353-362.
144. Spence, L.; Fauvel, M.; Petro, R.; Bloch, S. Haemagglutinin from Rotavirus. Lancet 1976, 2, 1023.
145. Ciarlet, M.; Estes, M.K. Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity. J. Gen. Virol. 1999, 80 (Pt 4), 943-948.
146. Banda, K.; Kang, G.; Varki, A. 'Sialidase sensitivity' of rotaviruses revisited. Nat. Chem. Biol. 2009, 5, 71-72.
147. Realpe, M.; Espinosa, R.; Lopez, S.; Arias, C.F. Rotaviruses require basolateral molecules for efficient infection of polarized MDCKII cells. Virus Res. 2010, 147, 231-241.
148. Blutt, S.E.; Conner, M.E. Rotavirus: to the gut and beyond! Curr. Opin. Gastro. 2007, 23, 39-43.
149. Blutt, S.E.; Matson, D.O.; Crawford, S.E.; Staat, M.A.; Azimi, P.; Bennett, B.L.; Piedra, P.A.; Conner, M.E. Rotavirus antigenemia in children is associated with viremia. PLoS Med. 2007, 4, e121.
150. Kuhlenschmidt, T.B.; Hanafin, W.P.; Gelberg, H.B.; Kuhlenschmidt, M.S. Sialic acid dependence and independence of group A rotaviruses. Adv. Exp. Med. Biol. 1999, 473, 309-317.
151. Lopez, J.A.; Maldonado, A.J.; Gerder, M.; Abanero, J.; Murgich, J.; Pujol, F.H.; Liprandi, F.; Ludert, J.E. Characterization of neuraminidase-resistant mutants derived from rotavirus porcine strain OSU. J. Virol. 2005, 79, 10369-10375.
152. Svensson, L. Group C rotavirus requires sialic acid for erythrocyte and cell receptor binding. J. Virol. 1992, 66, 5582-5585.
153. Kuhlenschmidt, M.S.; Rolsma, M.D.; Kuhlenschmidt, T.B.; Gelberg, H.B. Characterization of a porcine enterocyte receptor for group A rotavirus. Adv. Exp. Med. Biol. 1997, 412, 135-143.
154. Willoughby, R.E.; Yolken, R.H.; Schnaar, R.L. Rotaviruses specifically bind to the neutral glycosphingolipid asialo-GM1. J. Virol. 1990, 64, 4830-4835.
155. Superti, F.; Donelli, G. Gangliosides as binding sites in SA-11 rotavirus infection of LLC-MK2 cells. J. Gen. Virol. 1991, 72 2467-2474.
156. Srnka, C.A.; Tiemeyer, M.; Gilbert, J.H.; Moreland, M.; Schweingruber, H.; de Lappe, B.W.; James, P.G.; Gant, T.; Willoughby, R.E.; Yolken, R.H.; et al. Cell surface ligands for rotavirus: mouse intestinal glycolipids and synthetic carbohydrate analogs. Virology 1992, 190, 794-805.
157. Fukudome, K.; Yoshie, O.; Konno, T. Comparison of human, simian, and bovine rotaviruses for requirement of sialic acid in hemagglutination and cell adsorption. Virology 1989, 172, 196-205.
158. Ludert, J.E.; Feng, N.; Yu, J.H.; Broome, R.L.; Hoshino, Y.; Greenberg, H.B. Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo. J. Virol. 1996, 70, 487-493.
159. Ciarlet, M.; Crawford, S.E.; Estes, M.K. Differential infection of polarized epithelial cell lines by sialic acid-dependent and sialic acid-independent rotavirus strains. J. Virol. 2001, 75, 11834-11850.
160. Kraschnefski, M.J.; Bugarcic, A.; Fleming, F.E.; Yu, X.; von Itzstein, M.; Coulson, B.S.; Blanchard, H. Effects on sialic acid recognition of amino acid mutations in the carbohydrate-binding cleft of the rotavirus spike protein. Glycobiology 2009, 19, 194-200.
161. Dormitzer, P.R.; Sun, Z.Y.; Wagner, G.; Harrison, S.C. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J. 2002, 21, 885-897.
162. Monnier, N.; Higo-Moriguchi, K.; Sun, Z.Y.; Prasad, B.V.; Taniguchi, K.; Dormitzer, P.R. High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain. J. Virol. 2006, 80, 1513-1523.
163. Blanchard, H.; Yu, X.; Coulson, B.S.; von Itzstein, M. Insight into host cell carbohydrate-recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8*). J. Mol. Biol. 2007, 367, 1215-1226.
164. Imperiale, M.J.; Major, E.O. Polyomaviruses. In Fields Virology; Fifth ed.; Knipe, D. M.; Howley, P. M., Eds.; Lippincott Williams & Wilkins: Philadelphia, PA, 2007; Vol. 2, pp. 2263-2298.
165. Liddington, R.C.; Yan, Y.; Moulai, J.; Sahli, R.; Benjamin, T.L.; Harrison, S.C. Structure of simian virus 40 at 3.8-A resolution. Nature 1991, 354, 278-284.
166. Meneguzzi, G.; Pignatti, P.F.; Barbanti-Brodano, G.; Milanesi, G. Minichromosome from BK virus as a template for transcription in vitro. Proc. Natl. Acad. Sci. U. S. A. 1978, 75, 1126-1130.
167. Muller, U.; Zentgraf, H.; Eicken, I.; Keller, W. Higher order structure of simian virus 40 chromatin. Science 1978, 201, 406-415.
168. Stehle, T.; Gamblin, S.J.; Yan, Y.; Harrison, S.C. The structure of simian virus 40 refined at 3.1 A resolution. Structure 1996, 4, 165-182.
169. Salunke, D.M.; Caspar, D.L.; Garcea, R.L. Self-assembly of purified polyomavirus capsid protein VP1. Cell 1986, 46, 895-904.
170. Stehle, T.; Harrison, S.C. High-resolution structure of a polyomavirus VP1-oligosaccharide complex: implications for assembly and receptor binding. EMBO J. 1997, 16, 5139-5148.
171. Stehle, T.; Yan, Y.; Benjamin, T.L.; Harrison, S.C. Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 1994, 369, 160-163.
172. Neu, U.; Woellner, K.; Gauglitz, G.; Stehle, T. Structural basis of GM1 ganglioside recognition by simian virus 40. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 5219-5224.
173. Dubensky, T.W.; Freund, R.; Dawe, C.J.; Benjamin, T.L. Polyomavirus replication in mice: influences of VP1 type and route of inoculation. J. Virol. 1991, 65, 342-349.
174. Bauer, P.H.; Bronson, R.T.; Fung, S.C.; Freund, R.; Stehle, T.; Harrison, S.C.; Benjamin, T.L. Genetic and structural analysis of a virulence determinant in polyomavirus VP1. J. Virol. 1995, 69, 7925-7931.
175. Chen, B.J.; Atwood, W.J. Construction of a novel JCV/SV40 hybrid virus (JCSV) reveals a role for the JCV capsid in viral tropism. Virology 2002, 300, 282-290.
176. Neu, U.; Stehle, T.; Atwood, W.J. The Polyomaviridae: Contributions of virus structure to our understanding of virus receptors and infectious entry. Virology 2009, 384, 389-399.
177. Moriyama, T.; Marquez, J.P.; Wakatsuki, T.; Sorokin, A. Caveolar endocytosis is critical for BK virus infection of human renal proximal tubular epithelial cells. J. Virol. 2007, 81, 8552-8562.
178. Eash, S.; Querbes, W.; Atwood, W.J. Infection of vero cells by BK virus is dependent on caveolae. J. Virol. 2004, 78, 11583-11590.
179. Pho, M.T.; Ashok, A.; Atwood, W.J. JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J. Virol. 2000, 74, 2288-2292.
180. Norkin, L.C.; Anderson, H.A.; Wolfrom, S.A.; Oppenheim, A. Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles. J. Virol. 2002, 76, 5156-5166.
181. Pelkmans, L.; Kartenbeck, J.; Helenius, A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 2001, 3, 473-483.
182. Richterova, Z.; Liebl, D.; Horak, M.; Palkova, Z.; Stokrova, J.; Hozak, P.; Korb, J.; Forstova, J. Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei. J. Virol. 2001, 75, 10880-10891.
183. Magnuson, B.; Rainey, E.K.; Benjamin, T.; Baryshev, M.; Mkrtchian, S.; Tsai, B. ERp29 triggers a conformational change in polyomavirus to stimulate membrane binding. Mol. Cell 2005, 20, 289-300.
184. Schelhaas, M.; Malmstrom, J.; Pelkmans, L.; Haugstetter, J.; Ellgaard, L.; Grunewald, K.; Helenius, A. Simian Virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell 2007, 131, 516-529.
185. Jiang, M.; Abend, J.R.; Tsai, B.; Imperiale, M.J. Early events during BK virus entry and disassembly. J. Virol. 2009, 83, 1350-1358.
186. Lilley, B.N.; Gilbert, J.M.; Ploegh, H.L.; Benjamin, T.L. Murine polyomavirus requires the endoplasmic reticulum protein Derlin-2 to initiate infection. J. Virol. 2006, 80, 8739-8744.
187. Qian, M.; Cai, D.; Verhey, K.J.; Tsai, B. A lipid receptor sorts polyomavirus from the endolysosome to the endoplasmic reticulum to cause infection. PLoS Path. 2009, 5, e1000465.
188. Gross, L. A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc. Soc. Exp. Biol. Med. 1953, 83, 414-421.
189. Cahan, L.D.; Singh, R.; Paulson, J.C. Sialyloligosaccharide receptors of binding variants of polyoma virus. Virology 1983, 130, 281-289.
190. Fried, H.; Cahan, L.D.; Paulson, J.C. Polyoma virus recognizes specific sialyligosaccharide receptors on host cells. Virology 1981, 109, 188-192.
191. Cahan, L.D.; Paulson, J.C. Polyoma virus adsorbs to specific sialyloligosaccharide receptors on erythrocytes. Virology 1980, 103, 505-509.
192. Freund, R.; Calderone, A.; Dawe, C.J.; Benjamin, T.L. Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen. J. Virol. 1991, 65, 335-341.
193. Freund, R.; Garcea, R.L.; Sahli, R.; Benjamin, T.L. A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior. J. Virol. 1991, 65, 350-355.
194. Gilbert, J.; Dahl, J.; Riney, C.; You, J.; Cui, C.; Holmes, R.; Lencer, W.; Benjamin, T. Ganglioside GD1a restores infectibility to mouse cells lacking functional receptors for polyomavirus. J. Virol. 2005, 79, 615-618.
195. Sweet, B.H.; Hilleman, M.R. The vacuolating virus, S.V. 40. Proc. Soc. Exp. Biol. Med. 1960, 105, 420-427.
196. Garcea, R.L.; Imperiale, M.J. Simian virus 40 infection of humans. J. Virol. 2003, 77, 5039-5045.
197. Clayson, E.T.; Compans, R.W. Characterization of simian virus 40 receptor moieties on the surfaces of Vero C1008 cells. J. Virol. 1989, 63, 1095-1100.
198. Campanero-Rhodes, M.A.; Smith, A.; Chai, W.; Sonnino, S.; Mauri, L.; Childs, R.A.; Zhang, Y.; Ewers, H.; Helenius, A.; Imberty, A.; Feizi, T. N-glycolyl GM1 ganglioside as a receptor for simian virus 40. J. Virol. 2007, 81, 12846-12858.
199. Norkin, L.C. Simian virus 40 infection via MHC class I molecules and caveolae. Immunol. Rev. 1999, 168, 13-22.
200. Damm, E.M.; Pelkmans, L.; Kartenbeck, J.; Mezzacasa, A.; Kurzchalia, T.; Helenius, A. Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J. Cell Biol. 2005, 168, 477-488.
201. Kukura, P.; Ewers, H.; Muller, C.; Renn, A.; Helenius, A.; Sandoghdar, V. High-speed nanoscopic tracking of the position and orientation of a single virus. Nat. Methods. 2009, 6, 923-927.
202. Ewers, H.; Romer, W.; Smith, A.E.; Bacia, K.; Dmitrieff, S.; Chai, W.; Mancini, R.; Kartenbeck, J.; Chambon, V.; Berland, L.; Oppenheim, A.; Schwarzmann, G.; Feizi, T.; Schwille, P.; Sens, P.; Helenius, A.; Johannes, L. GM1 structure determines SV40-induced membrane invagination and infection. Nat. Cell Biol. 2010, 12, 11-18; sup pp 11-12.
203. Gardner, S.D.; Field, A.M.; Coleman, D.V.; Hulme, B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971, 1, 1253-1257.
204. Padgett, B.L.; Walker, D.L.; ZuRhein, G.M.; Eckroade, R.J.; Dessel, B.H. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971, 1, 1257-1260.
205. Jiang, M.; Abend, J.R.; Johnson, S.F.; Imperiale, M.J. The role of polyomaviruses in human disease. Virology 2009, 384, 266-273.
206. Sawa, H.; Komagome, R. The JC virus-like particle overlay assay. Methods Mol. Biol. 2005, 292, 175-186.
207. Feng, H.; Shuda, M.; Chang, Y.; Moore, P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319, 1096-1100.
208. Berns, K.; Parish, C.R. Parvoviridae. In Fields Virology; 5 ed.; Knipe, D. M., Howley, P. M., Ed. Lippincott Williams&Wilkins: Philadelphia, PA, 2007; Vol. 2, pp. 2437-2477.
209. Brown, K.E.; Young, N.S. Parvovirus B19 infection and hematopoiesis. Blood Rev. 1995, 9, 176-182.
210. Takahashi, Y.; Murai, C.; Shibata, S.; Munakata, Y.; Ishii, T.; Ishii, K.; Saitoh, T.; Sawai, T.; Sugamura, K.; Sasaki, T. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 8227-8232.
211. Brown, K.E.; Hibbs, J.R.; Gallinella, G.; Anderson, S.M.; Lehman, E.D.; McCarthy, P.; Young, N.S. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N. Engl. J. Med. 1994, 330, 1192-1196.
212. Chipman, P.R.; Agbandje-McKenna, M.; Kajigaya, S.; Brown, K.E.; Young, N.S.; Baker, T.S.; Rossmann, M.G. Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor. Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 7502-7506.
213. Simon, M.A. Simian parvoviruses: biology and implications for research. Comp. Med. 2008, 58, 47-50.
214. Grimm, D.; Kay, M.A. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr. Gene Ther. 2003, 3, 281-304.
215. Romer, W.; Berland, L.; Chambon, V.; Gaus, K.; Windschiegl, B.; Tenza, D.; Aly, M.R.; Fraisier, V.; Florent, J.C.; Perrais, D.; Lamaze, C.; Raposo, G.; Steinem, C.; Sens, P.; Bassereau, P.; Johannes, L. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature 2007, 450, 670-675.